Form 4 for PCVX Vaxcyte, Inc.
Accepted 2024-10-03 00:00:00 ET · period of report 2024-10-01 · accession 0001649094-24-000077 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2024-10-03 | 2024-10-01 | PCVX | PICKERING GRANT | CEO, Dir | S - Sale+OE | $114.25 | -55.0K | 461.6K | -11% | -$6.28M |
| DM | 2024-10-03 | 2024-10-01 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $5.35 | +40.0K | 470.2K | +9% | +$214.0K |
| DM | 2024-10-03 | 2024-10-01 | PCVX | PICKERING GRANT | CEO, Dir | M - OptEx | $0.00 | -40.0K | 238.7K | -14% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-10-01 | S | D | 4,305 | $113.35 | 465,914 | D | — | — | (F5) The price reported is a weighted-average price. The shares were sold at prices ranging from $112.705 to $113.65. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 2 | Common | Common Stock | 2024-10-01 | S | D | 5,474 | $114.98 | 450,219 | D | — | — | (F10) The price reported is a weighted-average price. The shares were sold at prices ranging from $114.80 to $115.32. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 3 | Common | Common Stock | 2024-10-01 | S | D | 9,627 | $114.28 | 455,693 | D | — | — | (F9) The price reported is a weighted-average price. The shares were sold at prices ranging from $113.76 to $114.74. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 4 | Common | Common Stock | 2024-10-01 | S | D | 4,899 | $113.37 | 465,320 | D | — | — | (F8) The price reported is a weighted-average price. The shares were sold at prices ranging from $112.745 to $113.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 5 | Common | Common Stock | 2024-10-01 | M | A | 20,000 | $5.35 | 470,219 | D | — | — | |
| 6 | Common | Common Stock | 2024-10-01 | S | D | 6,266 | $114.93 | 450,219 | D | — | — | (F7) The price reported is a weighted-average price. The shares were sold at prices ranging from $114.705 to $115.28. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 7 | Common | Common Stock | 2024-10-01 | S | D | 9,429 | $114.20 | 456,485 | D | — | — | (F6) The price reported is a weighted-average price. The shares were sold at prices ranging from $113.705 to $114.68. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 8 | Common | Common Stock | 2024-10-01 | M | A | 20,000 | $5.35 | 470,219 | D | — | — | |
| 9 | Common | Common Stock | 2024-10-01 | S | D | 4,288 | $114.99 | 450,219 | D | — | — | (F4) The price reported is a weighted-average price. The shares were sold at prices ranging from $114.77 to $115.275. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 10 | Common | Common Stock | 2024-10-01 | S | D | 7,088 | $114.27 | 454,507 | D | — | — | (F3) The price reported is a weighted-average price. The shares were sold at prices ranging from $113.76 to $114.73. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 11 | Common | Common Stock | 2024-10-01 | S | D | 3,624 | $113.38 | 461,595 | D | — | — | (F2) The price reported is a weighted-average price. The shares were sold at prices ranging from $112.76 to $113.735. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price. |
| 12 | Derivative | Stock Option (right to buy) | 2024-10-01 | M | D | 20,000 | $0.00 | 218,717 | D | $5.35 · — to 2030-04-17 | 20,000 Common Stock | (F13) Stock Option is fully vested and exercisable. |
| 13 | Derivative | Stock Option (right to buy) | 2024-10-01 | M | D | 20,000 | $0.00 | 238,717 | D | $5.35 · — to 2030-04-17 | 20,000 Common Stock | (F13) Stock Option is fully vested and exercisable. |